Related Experiment Video
Updated: Jun 5, 2025

Quantifying Cognitive Decrements Caused by Cranial Radiotherapy
Published on: October 18, 2011
Characterizing changes in executive functions and performance in daily activities after chemotherapy: A pre-post
Khawla Loubani1,2, Debbie Rand3, Abed Agbarya4,5
1Faculty of Health Sciences, Occupational Therapy Department, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Background:
Impairments in higher cognitive abilities (termed executive functions (EF) are common among individuals with cancer following chemotherapy and may impact their performance of daily activities. Our aim is to better understand the changes in EF and the impact on performance in daily activities of individuals with cancer pre- and post-chemotherapy.
Methods:
A convergent parallel mixed-method pre-post experimental design. Qualitative and quantitative data will be collected pre- and post-chemotherapy (12 weeks following chemotherapy commencement). Participants will be adult candidates for chemotherapy who are newly diagnosed with non-central nervous system malignancy, stages I-III. The Canadian Occupational Performance Measure will assess the performance of daily activities; secondary measures include EF, cognitive functioning, fatigue, and emotional well-being. Qualitative data will be collected via open-ended questions. Pre- and post-chemotherapy, quantitative and qualitative data will be analyzed separately and merged into an overall interpretation. It is expected that, pre-chemotherapy, no difficulties in performing daily activities will be revealed. Post-chemotherapy EF impairments will be apparent and their impact on the performance of daily activities will be identified.
Conclusions:
Integrating quantitative and qualitative measures will contribute to a comprehensive understanding of the individuals' cognitive needs and may enable the development of effective interventions to minimize deterioration in daily activities after chemotherapy.
Related Concept Videos
Cognitive Development During Adulthood
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

